Clinical trial
Phase 4 Study of Cognitive Therapy and Donepezil in Alzheimers Disease.
NCT00443014 is registered in ClinicalTrials.gov with University Hospital of North Norway as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 4 Study of Cognitive Therapy and Donepezil in Alzheimers Disease.
- Lead sponsor
- University Hospital of North Norway
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2003
- Completion date
- June 30, 2009
- Enrollment
- 187 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.